EU recommends suspending hundreds of drugs tested by Indian firm

By REUTERS
March 25, 2017 12:29
Breaking news

Breaking news. (photo credit: JPOST STAFF)

Europe's medicines regulator has recommended the suspension of more than 300 generic drug approvals and drug applications due to "unreliable" tests conducted by Indian contract research firm Micro Therapeutic Research Labs.

The decision, announced by the European Medicines Agency (EMA) on its website, is the latest blow for India's drug-testing industry, which has run into a series of problems with international regulators in recent years.

Nobody at the Chennai-based company was immediately available to comment.

The EMA said European officials had been investigating Micro Therapeutic's compliance with good clinical practice after Austrian and Dutch authorities raised concerns in February 2016.


Related Content

Breaking news
February 24, 2018
Russia calls for talks with U.S. on North Korea

By REUTERS

Israel Weather
  • 9 - 21
    Beer Sheva
    12 - 19
    Tel Aviv - Yafo
  • 9 - 15
    Jerusalem
    11 - 17
    Haifa
  • 14 - 26
    Elat
    11 - 21
    Tiberias